As recently reported, multiple sclerosis patients in the U.S. (age 22+) can with a prescription now obtain the portable neuromodulation stimulator (PoNS) device, which could improve walking ability in individuals with mild to moderate disease activity.1

​Once again, there’s more clinical evidence that dietary interventions can positively impact the course of many autoimmune diseases, including multiple sclerosis (MS).